AGM
XERS icon

Alpine Global Management’s Xeris Biopharma Holdings XERS Stock Holding History

Alpine Global Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-150,000
Closed -$701K – 294
2025
Q2 		$701K Buy
150,000
+50,000
+50% +$229K 0.16% 73
2025
Q1 		$549K Sell
100,000
-220,000
-69% -$888K 0.15% 84
2024
Q4 		$1.08M Buy
320,000
+160,000
+100% +$515K 0.14% 98
2024
Q3 		$456K Sell
160,000
-140,000
-47% -$360K 0.11% 110
2024
Q2 		$675K Hold
300,000
– – 0.12% 146
2024
Q1 		$663K Buy
300,000
+30,000
+11% +$77.6K 0.13% 112
2023
Q4 		$635K Sell
270,000
-30,000
-10% -$55.4K 0.17% 91
2023
Q3 		$558K Buy
300,000
+75,000
+33% +$172K 0.13% 76
2023
Q2 		$590K Sell
225,000
-175,000
-44% -$446K 0.16% 84
2023
Q1 		$652K Hold
400,000
– – 0.25% 43
2022
Q4 		$532K Hold
400,000
– – 0.18% 49
2022
Q3 		$624K Buy
400,000
+50,000
+14% +$82.7K 0.15% 60
2022
Q2 		$539K Buy
350,000
+33,480
+11% +$70.6K 0.14% 75
2022
Q1 		$810 Buy
316,520
+21,520
+7% +$52.6K 0.18% 81
2021
Q4 		$864K Sell
295,000
-75,000
-20% -$162K 0.13% 164
2021
Q3 		$907K Buy
370,000
+15,476
+4% +$44.9K 0.21% 86
2021
Q2 		$1.44M Sell
354,524
-70,476
-17% -$269K 0.2% 93
2021
Q1 		$1.92M Buy
425,000
+75,000
+21% +$404K 0.18% 82
2020
Q4 		$1.72M Sell
350,000
-202,856
-37% -$1.01M 0.35% 40
2020
Q3 		$3.28M Sell
552,856
-447,144
-45% -$1.79M 0.68% 24
2020
Q2 		$2.66M Buy
1,000,000
+494,683
+98% +$1.72M 0.47% 32
2020
Q1 		$985K Buy
+505,317
New +$2.17M 0.2% 87

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Alpine Global Management's XERS Position: Q3 2025 in Review

Alpine Global Management sold out of Xeris Biopharma Holdings (XERS) in Q3 2025, closing a stake of 150,000 shares — an estimated $701K sold.

Alpine Global Management first reported a position in XERS in Q1 2020 and held it in 22 quarters. The position peaked at $3.28M in Q3 2020. 230 funds tracked by Wall St. Rank hold XERS as of Q3 2025.

  • Alpine Global Management reported no remaining Xeris Biopharma Holdings position as of Q3 2025 after selling out during the quarter.
  • Alpine Global Management sold 150,000 Xeris Biopharma Holdings shares in Q3 2025, an estimated $701K.
  • Alpine Global Management first reported a position in Xeris Biopharma Holdings in Q1 2020 and held it in 22 quarters.
  • Alpine Global Management's Xeris Biopharma Holdings position peaked at $3.28M in Q3 2020.
  • 230 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2025.

Based on Alpine Global Management's 13F filing for Q3 2025, filed 14 Nov 2025.